Skip to main content
Pediatric Diabetes logoLink to Pediatric Diabetes
. 2024 Oct 18;2024:2283730. doi: 10.1155/2024/2283730

Preterm Labor and Hypertensive Disorders in Adolescent Pregnancies With Diabetes Between 2006 and 2019

Estelle Everett 1,2,3,, Christina S Han 4, Michael Richley 5, Timothy P Copeland 6, Tannaz Moin 1,2,3, Lauren E Wisk 2,7
PMCID: PMC11772008  NIHMSID: NIHMS2030668  PMID: 39872023

Abstract

Objective: We sought to evaluate the risk of preterm labor and hypertensive disorders in adolescent pregnancies with and without diabetes.

Methods: We evaluated 1,843,139 adolescents (≤20 years old) with labor and delivery admissions in the national Kids' Inpatient Database (KID) in years 2006, 2009, 2012, 2016, and 2019. International classification of disease codes was used to identify diabetes and medical factors affecting pregnancy. Weighted logistic regression was used to evaluate the association between diabetes and complications.

Results: Among admissions, 0.2% had type 1 diabetes (T1D), 0.2% had type 2 diabetes (T2D), and 0.7% had gestational diabetes (GDM); 10.1% of admissions were complicated by hypertensive disorders and 5.8% by preterm labor. Compared to adolescents without diabetes, those with diabetes had a higher prevalence of hypertensive disorders (T1D: 35.4%, T2D: 37.8%, GDM: 24.9%, None: 9.9%; p < 0.001) and preterm labor (T1D: 21.5%, T2D: 16.8%, GDM: 6.8%, none: 5.7%; p < 0.001). In adjusted models, odds of hypertensive disorders were higher in later study years (2019 vs. 2006 OR 1.85, 95% CI 1.77–1.94), among those with T1D (OR 4.32, 95% CI 3.94–4.74), with T2D (OR 4.18, 95% CI 3.79–4.61), and with GDM (OR 1.99, 95% CI 1.89–2.10). Adjusted odds of preterm labor were higher among those with T1D (OR 4.53, 95% CI 4.09–5.02), with T2D (OR 3.35, 95% CI 2.96–3.78), and with GDM (OR 1.18, 95% CI 1.08–1.28); disparities were seen by race/ethnicity, insurance, and income.

Conclusions: Diabetes, which is increasing among adolescents, is a significant risk factor for preterm labor and hypertensive disorders. Though the absolute number of adolescent pregnancies is decreasing, rates of hypertensive disorders have increased. Appropriate interventions are needed to ensure healthy outcomes for adolescents who are pregnant.

1. Introduction

Adolescent pregnancies, defined in the literature as occurring between ages 10 and 19, occurred in 16.7 per 1000 females and 4.6% of all live births in the United States in 2019 [1]. Although adolescent pregnancy childbearing rates have seen a dramatic decline since the 1990s, these rates remain substantially higher in the United States than other industrialized nations [1, 2]. Contributors to adolescent birth rates include racial and/or ethnic disparities, geopolitical influences on access to effective contraception and family planning, and other social determinants of health [3, 4].

Adolescent pregnancies are associated with increased rates of maternal and fetal complications, such as hypertensive disorders of pregnancy (including eclampsia), preterm birth, blood transfusions, congenital birth defects, low APGAR scores, suspected neonatal sepsis, and neonatal assisted ventilation [5]. The intersection of diabetes and adolescent pregnancy warrants even further concern. The diabetes epidemic has exponentially increased over the past few decades, with pregestational (type 1 and type 2) diabetes affecting 3.1%–6.8% of reproductive-aged women and 1%–2% of pregnancies in the United States. In 2019, an estimated 283,000 children and adolescents younger than age 20 years—or 35 per 10,000 US youths—had diagnosed diabetes [6]. Like adolescent pregnancies, diabetes in pregnancy is also associated with adverse maternal and fetal outcomes, including miscarriage, congenital fetal anomalies, preterm delivery, hypertensive disorders of pregnancy, fetal macrosomia, cesarean delivery, neonatal complications, maternal hyperglycemia, and worsening diabetic retinopathy and nephropathy [7].

Although the rates of gestational diabetes (GDM) in adolescent pregnancies have been explored, there is a paucity of data on the combination of pregestational diabetes and adolescent pregnancies, which is a vulnerable and high-risk subset of the obstetrics population in the United States. The objective of this study is threefold: (1) to describe the obstetrical risks of two common diabetes complications (hypertensive disorders and preterm labor with delivery) and determine how these outcomes are modified by diabetes status and type, (2) to evaluate what other patient and clinical factors predict increased risk for these serious complications in this understudied population, and (3) to evaluate the health expenditures associated with these complicated delivery admissions.

2. Methods

2.1. Study Population and Data Elements

We used the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID) developed by the Agency for Healthcare Research and Quality (AHRQ) [8]. As previously described [9], KID is a publicly available deidentified database containing admissions from children and youth ≤20 years old (yo) from 42,000 hospitals across 46 states, sampled 80% of nonnewborn admissions. KID data are available every 3 years, but 2015 data were not released, and instead, 2016 data were released due to the transition from International Code of Diseases (ICD)-9 to ICD-10 coding.

We identified labor and delivery admissions in years 2006, 2009, 2012, 2016, and 2019 using ICD codes for normal delivery and other indications for care in labor and delivery (ICD-9 codes 650–659 and ICD-10 codes O61-O77, O80, and O82). We classified patients as having type 1 diabetes (T1D; ICD-9: 250.X1, 250.X3, ICD-10: E10), type 2 diabetes (T2D; ICD-9: 250.X0, 250.X2, ICD-10: E11), GDM (ICD-9: 648.0 without codes for T1D or T2D, ICD-10: O244), or having no diabetes (none of the aforementioned codes). Our clinical outcomes of hypertensive disorders included diagnoses of hypertension (HTN) complicating pregnancy childbirth and the puerperium (ICD-9: 642), pre-existing HTN complication pregnancy childbirth and the puerperium (ICD-10: O10), pre-existing HTN with pre-eclampsia (ICD-10: O11), pregestational HTN without significant proteinuria (ICD-10: O13), pre-eclampsia (ICD-10: O14), eclampsia (ICD-10: O15), and unspecified maternal HTN (ICD-10: O16). Preterm labor with delivery, henceforth referred to as preterm labor, was defined as a diagnosis for early onset of delivery, delivered with or without mention of antepartum condition (ICD-9: 644.21), and preterm labor with preterm delivery (ICD-10: O601). We adjusted our analyses for several patient level (e.g., age, race/ethnicity, income, comorbidities, and urban residence) and hospital level (e.g., region, size, and ownership) covariates. The definitions of these factors were described in a former publication [9]. Severity of illness on admission was determined using All Patient Refined Diagnosis-Related Groups, [10] which classifies patients according to their reasons for admission, severity of illness, risk of mortality, resource intensity, and disposition

2.2. Statistical Analysis

Weights provided by KID were used to generate nationally representative estimates of hospital admissions and all analyses accounted for the stratified sampling design. We used descriptive statistics to summarize the characteristics of all labor and delivery admissions. Counts less than or equal to 10 are noted as ≤10 per HCUP policy to preserve the amenity and privacy rights of those individuals. A chi-squared test was used to evaluate for unadjusted statistical differences in demographics, clinical features, and between diabetes status and type. We performed logistic regression to evaluate the adjusted association of diabetes status and type and hypertensive disorders and preterm labor after adjusting for confounding factors. All analyses were performed with Stata version 15.1 (StataCorp, College Station, TX). We retained missing/unknown categories for all variables with missing data, resulting in a consistent sample across all analyses. This study was institutional review board (IRB) exempt as it was a secondary analysis of pre-existing and deidentified data. This report follows the strengthening the reporting of observational studies in epidemiology (STROBE) reporting guidelines for cross-sectional studies.

3. Results

3.1. Characteristics of Labor and Delivery Admissions by Diabetes Type

There were 1,843,139 labor and delivery admissions across our study years, and the number of admissions decreased over time from 477,044 in 2006 to 251,439 in 2019 (Table 1). These admissions occurred most commonly in those >15 yo (98%) of non-Hispanic White race (35.6%), with public insurance (72.4%), living in urban areas (80.4%), of the lowest income quartile (41.2%), and in hospitals in the southern United States (44.5%). Of these admissions, 3327 (0.2%) had T1D, 3050 (0.2%) had T2D, and 12,909 (0.7%) had GDM. Pregnancies in the youngest age group (9–11 yo) occurred only in patients without diabetes. The racial–ethnic breakdown of admissions varied by diabetes type. Admissions with T1D and GDM occurred more commonly in those who were non-Hispanic White. T2D occurred similarly and most frequently in those who were non-Hispanic Black and non-Hispanic White race. Across all diabetes types, admissions occurred more prevalently in those with public insurance, with income in the lower two income quartiles, living in urban areas, and living in southern regions.

Table 1.

Patient and hospital characteristics of labor and delivery admissions by diabetes type.

Characteristic No diabetes (%) Type 1 (%) Type 2 (%) Gestational DM (%) Total % p-Value
n 1,823,854 3327 3050 12,909 1,843,139
Age <0.001
 9–11 381 0.0% 0 0.0% 0 0.0% 0 0.0% 381 0.0%
 12–14 18,866 1.0% 25 0.8% 20 0.7% 35 0.3% 18,946 1.0%
 15–17 377,105 20.7% 554 16.6% 392 12.9% 1397 10.8% 379,448 20.6%
 18–20 1,425,279 78.1% 2748 82.6% 2635 86.4% 11,476 88.9% 1,442,138 78.2%
 Unknown 2223 0.1% 0 0.0% <10 0.1% 0 0.0% 2226 0.1%
Race/ethnicity
 White 648,103 35.5% 1593 47.9% 857 28.1% 5557 43.0% 656,110 35.6% <0.001
 Black 338,730 18.6% 628 18.9% 878 28.8% 1966 15.2% 342,202 18.6%
 Hispanic 495,136 27.1% 599 18.0% 754 24.7% 3790 29.4% 500,280 27.1%
 Asian or Pacific Islander 24,413 1.3% 29 0.9% 34 1.1% 249 1.9% 24,724 1.3%
 Native American 17,546 1.0% 27 0.8% 48 1.6% 269 2.1% 17,890 1.0%
 Other 72,664 4.0% 95 2.8% 108 3.5% 501 3.9% 73,367 4.0%
 Unknown 227,262 12.5% 357 10.7% 371 12.2% 576 4.5% 228,566 12.4%
Payer
 Private 397,232 21.8% 963 29.0% 561 18.4% 2927 22.7% 401,684 21.8%
 Public 1,321,010 72.4% 2197 66.0% 2310 75.8% 9486 73.5% 1,335,002 72.4%
 Self-pay 55,428 3.0% 40 1.2% 85 2.8% 202 1.6% 55,755 3.0%
 Other/unknown 50,185 2.8% 126 3.8% 93 3.1% 294 2.3% 50,698 2.8%
Urbanicity <0.001
 Urban areas 1,466,140 80.4% 2586 77.7% 2450 80.3% 10,265 79.5% 1,481,440 80.4%
 Nonurban areas 348,293 19.1% 725 21.8% 589 19.3% 2629 20.4% 352,236 19.1%
Household income
 Quartile 4 164,768 9.0% 316 9.5% 236 7.8% 1063 8.2% 166,384 9.0% <0.001
 Quartile 3 364,165 20.0% 700 21.1% 479 15.7% 2625 20.3% 367,969 20.0%
 Quartile 2 509,169 27.9% 1002 30.1% 796 26.1% 3782 29.3% 514,749 27.9%
 Quartile 1 751,451 41.2% 1245 37.4% 1492 48.9% 5300 41.1% 759,489 41.2%
 Unknown 34,301 1.9% 63 1.9% 46 1.5% 138 1.1% 34,548 1.9%
Region of hospital
 Northeast 211,404 11.6% 429 12.9% 298 9.8% 1450 11.2% 213,581 11.6% <0.001
 Midwest 386,347 21.2% 805 24.2% 618 20.3% 2901 22.5% 390,671 21.2%
 South 811,250 44.5% 1446 43.5% 1551 50.9% 5648 43.8% 819,895 44.5%
 West 414,853 22.7% 647 19.5% 582 19.1% 2910 22.5% 418,993 22.7%
Hospital ownership <0.001
 Private 1,322,124 72.5% 2351 70.7% 2087 68.4% 10,753 83.3% 1,337,314 72.6%
 Public 501,730 27.5% 976 29.3% 963 31.6% 2156 16.7% 505,825 27.4%
Hospital size <0.001
 Large 1,073,768 58.9% 2236 67.2% 2015 66.1% 7268 56.3% 1,085,287 58.9%
 Medium 486,904 26.7% 743 22.3% 700 22.9% 3337 25.9% 491,684 26.7%
 Small 239,815 13.1% 287 8.6% 285 9.4% 2295 17.8% 242,682 13.2%
 Unknown 23,367 1.3% 60 1.8% 49 1.6% <10 0.1% 23,485 1.3%
Year <0.001
 2006 475,604 26.1% 621 18.7% 659 21.6% 160 1.2% 477,044 25.9%
 2009 454,795 24.9% 634 19.0% 722 23.7% 124 1.0% 456,275 24.8%
 2012 359,306 19.7% 675 20.3% 655 21.5% 99 0.8% 360,736 19.6%
 2016 290,039 15.9% 752 22.6% 534 17.5% 6321 49.0% 297,645 16.1%
 2019 244,110 13.4% 645 19.4% 480 15.7% 6204 48.1% 251,439 13.6%

Labor and delivery admissions were more complicated, lengthy, and costly in patients with diabetes compared to those without diabetes. Patients without diabetes more often had admissions classified as having a minor severity of illness (60%), while those with GDM had primarily a moderate severity of illness (62.3%), and those with T1D and T2D had a major severity of illness (56.3% and 58.8%, respectively). The mean length of stay and admission charge were 2.59 days (95% CI 2.58–2.60) and $15,316 ($15,113–$15,517) in those without diabetes and highest in those with T1D at 4.81 days (4.58–5.04 days) and $29,279 ($27,942–$30,616). Those with diabetes were most likely to have comorbid conditions such as obesity, renal disease, multiple gestations, and hospital complications such as fetal abnormality and premature rupture of membranes (PROM; Table 2). Delivery by cesarean section occurred at a frequency of 19% in the general population. Among those with diabetes, cesareans occurred most frequently in those with T1D (50.6%), followed by T2D (42.7%) and GDM (27.3%).

Table 2.

Clinical characteristics of labor and delivery admissions by diabetes type.

Characteristic No diabetes (%) Type 1 (%) Type 2 (%) Gestational (%) Total (%) p-Value
n 1,823,854 99.0% 3327 0.2% 3050 0.2% 12,909 0.7% 1,843,139 100%
Preterm labor 104,246 5.7% 717 21.5% 513 16.8% 875 6.8% 106,351 5.8% <0.001
Hypertensive disorders 179,982 9.9% 1177 35.4% 1152 37.8% 3214 24.9% 185,525 10.1% <0.001
Multiple gestations 9553 0.5% 15 0.5% 22 0.7% 135 1.1% 9726 0.5% <0.001
PROM 83,728 4.6% 240 7.2% 172 5.6% 940 7.3% 85,080 4.6% <0.001
Premature PROMb 16,891 0.9% 116 3.5% 61 2.0% 427 3.3% 17,494 0.9% <0.001
Fetal abnormality 22,085 1.2% 144 4.3% 95 3.1% 154 1.2% 22,478 1.2% <0.001
Obesity 68,462 3.8% 303 9.1% 701 23.0% 2582 20.0% 72,049 3.9% <0.001
Renal disease 1327 0.1% 68 2.1% 34 1.1% 33 0.3% 1462 0.1% <0.001
C-section 343,866 18.9% 1685 50.6% 1302 42.7% 3526 27.3% 350,379 19.0% <0.001
Died 75 0.0% <10 0.0% <10 0.1% <10 0.0% 79 0.0% 0.4286
Severity of illness <0.001
 No class 274 0.0% <10 0.0% <10 0.0% <10 0.0% 278 0.0%
 Minor 1,101,877 60.4% 41 1.2% 36 1.2% 2894 22.4% 1,104,848 59.9%
 Moderate 614,776 33.7% 1303 39.2% 1155 37.9% 8044 62.3% 625,279 33.9%
 Major 102,977 5.7% 1873 56.3% 1794 58.8% 1911 14.8% 108,554 5.9%
 Extreme 3950 0.2% 109 3.3% 64 2.1% 58 0.4% 4180 0.2%
 LOS (days)a 2.59 2.58–2.60 4.81 4.58–5.04 4.23 3.99–4.46 3.30 3.23–3.80 1.60 2.59–2.62
Total charges (2019 dollars)a $15,316 $15,113– $15,517 $29,279 $27,942–$30,616 $25,237 $23,946–$26,527 $24,160 $23,430–$24,890 $15,420 15,215–15,623

aMean reported with 95% confidence interval.

bPrevalence reported for only years 2016 and 2019.

3.2. Hypertensive Disorders

Hypertensive disorders were observed in 10% of labor and delivery admissions and were common among adolescents with T2D (37.8%), followed by those with T1D (35.4%) and GDM (24.9%). Those with hypertensive disorders were more likely to be obese (10.9% vs. 3.1%), have renal disease (0.4% vs. 0%), multiple gestations (1.2% vs. 0.5%), and fetal abnormality (1.5% vs. 1.2%). PROM occurred less in those with hypertensive disorders (3.5% vs. 4.7%) (Table 3). C-sections occurred in 33.5% with hypertensive disorder compared to 14.4% in those without. Length of stay and hospital charge were higher in those with a hypertensive disorder (3.60 [95% CI 3.58–3.63] and $22,784 [$22,422–23,145] vs. 2.49 days [95% CI 248–2.50] and $14,596 [95% CI $14,404–$14,7882]).

Table 3.

Clinical characteristics of pregnancies complicated by hypertensive disorder or preterm labor.

Characteristic Hypertensive disorder Preterm labor
NO (%) YES (%) NO (%) YES (%)
N 1,657,614 185,525 1,736,788 106,351
Obesity 51,755 3.1% 20,293 10.9% 68,434 3.9% 3615 3.4%
Renal disease 733 0.0% 729 0.4% 1241 0.1% 221 0.2%
Multiple gestations 7503 0.5% 2222 1.2% 5118 0.3% 4608 4.3%
PROM 78,636 4.7% 6445 3.5% 69,681 4.0% 15,399 14.5%
Premature PROMb 183,787 99.1% 1738 0.9% 17,494 0.9% 97,199 91.4%
Fetal abnormality 19,702 1.2% 2776 1.5% 19,399 1.1% 3079 2.9%
Cesarean section 288,204 17.4% 62,174 33.5% 322,951 18.6 27,427 25.8%
LOSa 2.49 2.48–2.50 3.60 3.58–3.63 2.54 2.53–2.55 3.72 3.67–3.77
Total chargesa (2019 dollars) $14,596 $14,404–$14,788 $22,784 $ 22,422–$23,145 $15,091 $14,892–$15,290 $20,784 $20,410–$21,157

Abbreviations: LOS, length of stay; PROM, premature rupture of membranes.

aMean and 95% confidence interval reported.

bPrevalence reported for only years 2016 and 2019.

In adjusted models, the odds of hypertensive disorders increased over time, with a 1.85 higher odds in 2019 as compared to 2006 (95% CI 1.77–1.94, p < 0.001; Table 4). As compared to adolescents without diabetes, those with T1D had the highest odds of hypertensive disorder (OR 4.32, 95% CI 3.91–4.74, p < 0.001), followed by T2D (OR 4.18, 95% CI 3.79–4.61, p < 0.001) and GDM (OR 1.99, 95% CI 1.89–2.10, p < 0.001). Other notable predictors of hypertensive disorders were being in the age group 12–14 yo compared to 18–20 yo (OR 1.29, 95% CI 1.22–1.36, p < 0.001) and being of Black race (OR 1.26, 95% CI 1.23–1.30, p < 0.001) or Native American race (OR 1.15, 95% CI 1.05–1.23, p < 0.003) compared to the White race. Those of Hispanic and Asian ancestry had lower odds of hypertensive disorder (OR 0.83, 0.81–0.85, p < 0.001, and OR 0.76, 0.68–0.84, p < 0.001, respectively). Patients of the lowest income quartile had higher odds for hypertensive disorder compared to the highest income quartile (OR 1.06, 95% CI 1.03–1.10, p < 0.001). Those with multiple gestations (OR 2.33, 95% CI 2.19–2.47, p < 0.001), obesity (OR 3.19, 95% CI 3.11–3.28, p < 0.001), and renal disease (OR 6.59, 95% CI 5.76–7.55, p < 0.001) were also at increased odds for a hypertensive disorder. We performed a sensitivity analysis to evaluate for differences in the predictors of severe hypertensive disorders (e.g., eclampsia, HELLP [hemolysis, elevated liver enzymes and low platelets], and pre-existing HTN with superimposed pre-eclampsia) compared to milder hypertensive disorder (e.g., mild transient HTN, mild pre-eclampsia, etc.) and found a similar trend as previously noted with patients with T1D possessing the highest risk (OR 2.19, 95% CI 1.88–2.54).

Table 4.

Odds of preterm labor and hypertensive disorder.

Variable Preterm labor Hypertensive disorder
OR 95% CI p-Value OR 95% CI p-Value
Age
 9–11 0.21 0.07 0.66 0.008 0.34 0.16 0.72 0.005
 12–14 1.77 1.66 1.88 <0.001 1.29 1.22 1.36 <0.001
 15–17 1.15 1.12 1.17 <0.001 1.07 1.05 1.08 <0.001
 18–20 Reference Reference
 Unknown 1.17 0.92 1.49 0.194 0.69 0.52 0.92 0.010
Race/ethnicity
 White Reference Reference
 Black 1.27 1.24 1.31 <0.001 1.26 1.23 1.30 <0.001
 Hispanic 0.94 0.92 0.97 <0.001 0.83 0.81 0.85 <0.001
 Asian or Pacific Islander 1.23 1.15 1.32 <0.001 0.76 0.68 0.84 <0.001
 Native American 1.08 0.98 1.18 0.120 1.15 1.05 1.26 0.003
 Other/unknown 1.05 1.00 1.09 0.039 0.95 0.91 0.99 0.006
Diabetes status and type
 No diabetes Reference Reference
 Type 1 4.53 4.09 5.02 <0.001 4.32 3.94 4.74 <0.001
 Type 2 3.35 2.96 3.78 <0.001 4.18 3.79 4.61 <0.001
 Gestational diabetes 1.18 1.08 1.28 <0.001 1.99 1.89 2.10 <0.001
Co-existing conditionsa
 Multiple gestations 14.94 14.21 15.71 <0.001 2.33 2.19 2.47 <0.001
 Obesity 0.79 0.75 0.83 <0.001 3.19 3.11 3.28 <0.001
 Renal disease 2.36 1.96 2.83 <0.001 6.59 5.76 7.55 <0.001
Payer
 Private Reference Reference
 Public 1.03 1.01 1.06 0.002 0.94 0.92 0.96 <0.001
 Self-pay or no charge 1.23 1.17 1.30 <0.001 0.82 0.77 0.87 <0.001
 Other/unknown 1.12 1.06 1.19 <0.001 0.95 0.91 1.00 0.036
Household income
 Quartile 1 1.09 1.05 1.13 <0.001 1.06 1.03 1.10 <0.001
 Quartile 2 1.04 1.01 1.08 0.023 1.01 0.98 1.04 0.657
 Quartile 3 1.01 0.98 1.05 0.371 1.01 0.98 1.04 0.350
 Quartile 4 Reference Reference
 Unknown 1.05 0.97 1.12 0.217 1.09 1.00 1.19 0.048
Urbanicity
 Nonurban areas 0.96 0.93 0.99 0.004 0.91 0.89 0.94 <0.001
 Urban areas Reference Reference
 Unknown 1.09 0.93 1.28 0.274 0.98 0.86 1.11 0.698
Region of hospital
 Northeast Reference Reference
 Midwest 1.03 0.98 1.08 0.306 1.00 0.95 1.06 0.904
 South 1.04 1.00 1.09 0.055 1.07 1.02 1.12 0.009
 West 0.97 0.92 1.01 0.161 0.91 0.86 0.96 <0.001
Hospital ownership
 Public 1.13 1.09 1.17 <0.001 1.22 1.17 1.27 <0.001
 Private Reference Reference
Hospital size
 Small 0.76 0.73 0.80 <0.001 0.87 0.84 0.91 <0.001
 Medium 0.89 0.86 0.92 <0.001 0.91 0.87 0.94 <0.001
 Large Reference Reference
 Unknown 1.29 1.12 1.48 <0.001 1.24 1.09 1.41 0.001
Year
 2006 Reference Reference
 2009 1.00 0.97 1.04 0.930 1.13 1.09 1.17 <0.001
 2012 0.95 0.91 0.99 0.017 1.19 1.13 1.25 <0.001
 2016 1.15 1.10 1.20 <0.001 1.38 1.32 1.44 <0.001
 2019 1.07 1.03 1.12 0.001 1.85 1.77 1.94 <0.001

Note: Variables included in this adjusted model include age, race/ethnicity, diabetes status/type, select co-existing conditions (multiple gestations, obesity, and renal disease), payer, household income, urbanity, region of the hospital, hospital ownership, hospital size, and year.

aVariables listed under co-existing conditions are all binary variables (condition present vs. absent), so the reference level is condition absent, but this has been omitted from the table for brevity.

3.3. Preterm Labor

Preterm labor occurred in 5.8% of pregnancies, and those with T1D had the highest proportion of preterm labor at 21.5%, followed by T2D (16.8%) and GDM (6.8%). Those with preterm labor were more likely to have multiple gestations (4.3% vs. 0.3%), PROM (14.5% vs. 4%), and fetal abnormality (2.9% vs. 1.1%). C-sections occurred in 25.7% of deliveries with preterm labor compared to 18.6% in those without. Length of stay and hospital charge were higher in those with preterm labor (3.72 days [95% CI 3.67–3.77] and $20,784 [95% CI $20,410–21,157] vs. 2.54 days [95% CI 2.53–2.55] and $15,091 [95% CI $14,892–$15,290]).

In adjusted models, the odds of preterm labor varied over time but trended upward with the odds of preterm in 2016 (OR 1.15, 95% CI 1.10–1.2, p < 0.001) and 2019 (OR 1.07, 95% CI 1.03–1.12, <p=0.001) being higher than in 2006. Patients with T1D had the highest odds for preterm labor (OR 4.53, 95% CI 4.09–5.02), followed by T2D (OR 2.96, 95% CI 2.96–3.78, p < 0.001) and GDM (OR 1.18, 95% CI 1.08–1.28, p < 0.001) compared to those without diabetes. Other notable predictors of preterm labor include age 12–14 (OR 1.77, 95% CI 1.66–1.88, p < 0.001) compared to 18–20 yo and being of Black race (OR 1.27 (OR 1.24−1.31, p < 0.001) or Asian race (OR 1.23, OR 1.15–1.32, p < 0.001). Those of Hispanic ethnicity were at lower risk of preterm labor (OR 0.94, 95% CI 0.92–0.97, p < 0.001). Patients without private insurance (e.g., public, self-pay, and others) and those in the lowest two income quartile (compared to highest income quartile) also had higher odds of preterm labor. Lastly, those with multiple gestations (OR 14.91, 95% CI 14.21–15.71, p < 0.001) and renal disease (OR 2.36, 95% CI 1.96–2.83, p < 0.001) had increased odds for preterm labor, while those with obesity had lower odds (OR 0.79 95% CI 0.75–0.83, p < 0.001).

4. Discussions

While we found that adolescent pregnancies have decreased over the past two decades, our study shows concerning rises in odds of both hypertensive disorders in pregnancy and preterm labor. The decreasing frequency of adolescent pregnancies over the time period analyzed matches the temporal trends described previously in the literature [1]. However, social and geographic determinants of health, including public insurance, lower socioeconomic status, urban locale, and location in Southern states of the United States, continue to be associated with adolescent pregnancies in those with and without diabetes. These data suggest progress toward the Healthy People 2030 goal of reducing pregnancies in adolescents but not of the overarching goal of eliminating disparities and achieving health equity [11]. A root cause analysis must be conducted to determine the barriers to decreasing adolescent birth rates in these populations [12].

Adolescent pregnancies are at inherently higher risk of adverse pregnancy outcomes, and this risk is further potentiated by concomitant diabetes. We report higher odds of multiple maternal and fetal sequelae, including fetal anomaly, preterm delivery, hypertensive disorders, cesarean delivery, and increased costs of care during the labor and delivery admission, when compared to adolescent pregnancies without diabetes. The estimated costs of adolescent pregnancies are likely further compounded when the adolescents enter pregnancy with a comorbid diabetes diagnosis.

The prevalence of diabetes in youth has increased significantly in the last two decades and continues to rise in recent years [13, 14]. While the pregnancies in persons with diabetes were relatively stable during this study, in the setting of decreasing rates of overall adolescent deliveries, this is concerning for a potential increase in pregnancies in those with diabetes over time, which may result in increased pregnancy complications (e.g., hypertensive disorders and preterm labor) in this population. Additionally, rising rates of obesity are likely to increase the risk of some pregnancy complications. This may not only have short-term implications but also impact long-term outcomes given the association of future cardiovascular disease in women who have hypertensive disorders during pregnancy [15]. We found that obesity was associated with lower rate of preterm labor. This is consistent with existing literature showing that obese mothers are more likely to have postterm birth than preterm birth [16].

Preconception optimization of diabetes care and reproductive planning discussions continue to be suboptimal in all populations but particularly so in adolescents [17, 18]. These findings may be translated as a call to arms for pediatricians and endocrinologists managing adolescents with diabetes to be trained in contraception and reproductive health counseling and to include gynecologists and maternal–fetal medicine specialists in the multidisciplinary management of this population.

This study has some limitations, including those inherent to retrospective studies involving databases derived from administrative coding. This includes misclassification of diabetes type or pregnancy complications and the inability to account for change in coding practices in the setting of ICD-9 to ICD-10 change, which, for example, may account for the significant increase in case detection in GDM after transition to ICD-10. Furthermore, we were unable to pair data on the neonates resulting from these pregnancies, which carry additional public health and societal implications. Despite these limitations, this study captures the most recent estimate of adolescent pregnancies suing the largest national population-based database of pediatric discharges, which strengthen the ability to study this specific high-risk subpopulation of adolescent pregnancies. In addition to describing the associated clinical outcomes, we also evaluated the healthcare costs associated with the comorbid pregnancies during the labor and delivery admission. Future work will focus on the impact duration of diabetes, glycemic control, approach to diabetes management, and how they modify pregnancy outcomes in this population.

5. Conclusions

Pregnancy in adolescence is associated with higher rates of complications, and when compounded by a diagnosis of diabetes, these risks increase further. Given the rising rates of diabetes in this age group, better strategies are needed to improve reproductive planning discussions and prenatal optimization in this population and high risk for poor outcomes.

Data Availability Statement

The data that support the findings of this study are available from the Agency for healthcare Research and Quality's (AHRQ) Healthcare Cost and Utilization Project (HCUP). Restrictions apply to the availability of these data, which were used under license for this study.

Disclosure

The opinions expressed in this article are the author's own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, Department of Veterans Affairs or the United States government. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Conflicts of Interest

The authors declare no conflicts of interest.

Author Contributions

E.E. contributed to the study conceptualization and design, the data analysis, result interpretation, and the first draft of the manuscript and its subsequent revisions. C.S.H. contributed to the design, result interpretation, and initial draft of the manuscript and subsequent revisions. M.R. contributed to the study design and result interpretation. T.M. contributed to the data analysis and revision of the manuscript. T.M. contributed to the revision of the manuscript. L.E.W. contributed to the study conceptualization and design, result interpretation, and revision of the manuscript.

Funding

We wish to also acknowledge the generous funding support from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) K23DK132482 (PI: Everett), L40DK129996 (PI: Everett), and K01DK116932 (PI: Wisk). Research reported in this publication was supported by the Office of Disease Prevention (ODP), the Office of Nutrition Research (ONR), the Chief Officer for Scientific Workforce Diversity (COSWD), and the Office of Behavioral and Social Sciences Research (OBSSR) of the National Institutes of Health under award number U24DK132746-01, UCLA LIFT-UP (Leveraging Institutional support for Talented, Underrepresented Physicians and/or Scientists).

References

  • 1.Martin J., Hamilton B., Osterman M., Driscoll A. Births: Final Data for 2019. National Vital Statistic Reports . 2021;70(2):1–51. [PubMed] [Google Scholar]
  • 2.Sedgh G., Finer L. B., Bankole A., Eilers M. A., Singh S. Adolescent Pregnancy, Birth, and Abortion Rates Across Countries: Levels and Recent Trends. Journal of Adolescent Health . 2015;56(2):223–230. doi: 10.1016/j.jadohealth.2014.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Penman-Aguilar A., Carter M., Snead M. C., Kourtis A. P. Socioeconomic Disadvantage as a Social Determinant of Teen Childbearing in the U.S. Public Health Reports . 2013;128(2_suppl1):5–22. doi: 10.1177/00333549131282S102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kaneshiro B., Darroch J. E. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity. Obstetrics and Gynecology . 2017;129(5):e142–e149. doi: 10.1097/AOG.0000000000002045. [DOI] [PubMed] [Google Scholar]
  • 5.Eliner Y., Gulersen M., Kasar A., et al. Maternal and Neonatal Complications in Teen Pregnancies: A Comprehensive Study of 661,062 Patients. Journal of Adolescent Health . 2022;70(6):922–927. doi: 10.1016/j.jadohealth.2021.12.014. [DOI] [PubMed] [Google Scholar]
  • 6.Prevalence of Diagnosed Diabetes | Diabetes | CDC. 2023. Accessed August 4 https://www.cdc.gov/diabetes/data/statistics-report/diagnosed-diabetes.html.
  • 7.ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstetrics & Gynecology . 2018;132(6):e228–e248. doi: 10.1097/AOG.0000000000002960. [DOI] [PubMed] [Google Scholar]
  • 8.HCUP- KID Overview. 2020. Accessed May 29 https://www.hcup-us.ahrq.gov/kidoverview.jsp.
  • 9.Everett E. M., Copeland T. P., Moin T., Wisk L. E. National Trends in Pediatric Admissions for Diabetic Ketoacidosis, 2006–2016. The Journal of Clinical Endocrinology & Metabolism . 2021;106(8):2343–2354. doi: 10.1210/clinem/dgab287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Goldfield R. F. A. N., Hughes J. S., McCullough B. A. B. E., et al. All Patient Refined Diagnosis Related Groups (APR-DRGs) Methodology Overview 3M Health Information Systems. 2003. Accessed August 31, 2021.
  • 11.US DHHS. Reduce Pregnancies in Adolescents—FP-03-Healthy People 2030 | health.gov. 2023. Accessed August 4, 2023 https://health.gov/healthypeople/objectives-and-data/browse-objectives/family-planning/reduce-pregnancies-adolescents-fp-03.
  • 12.Fuller T. R., White C. P., Chu J., et al. Social Determinants and Teen Pregnancy Prevention: Exploring the Role of Nontraditional Partnerships. Health Promotion Practice . 2018;19(1):23–30. doi: 10.1177/1524839916680797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Perng W., Conway R., Mayer-Davis E., Dabelea D. Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic. Diabetes Care . 2023;46(3):490–499. doi: 10.2337/dci22-0046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.D’Souza D., Empringham J., Pechlivanoglou P., Uleryk E. M., Cohen E., Shulman R. Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. JAMA Network Open . 2023;6(6) doi: 10.1001/jamanetworkopen.2023.21281.e2321281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Khosla K., Heimberger S., Nieman K. M., et al. Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension. Hypertension . 2021;78(4):927–935. doi: 10.1161/HYPERTENSIONAHA.121.16506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Magann E. F., Doherty D. A., Chauhan S. P., Klimpel J. M., Huff S. D., Morrison J. C. Pregnancy, Obesity, Gestational Weight Gain, and Parity as Predictors of Peripartum Complications. Archives of Gynecology and Obstetrics . 2011;284(4):827–836. doi: 10.1007/s00404-010-1754-0. [DOI] [PubMed] [Google Scholar]
  • 17.Roberts A. J., Sauder K., Stafford J. M., et al. Preconception Counseling in Women With Diabetes: The SEARCH for Diabetes in Youth Study. Clinical Diabetes . 2023;41(2):177–184. doi: 10.2337/cd22-0030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sievwright K. M., Moreau C., Li M., Ramaiya A., Gayles J., Blum R. W. Adolescent–Parent Relationships and Communication: Consequences for Pregnancy Knowledge and Family Planning Service Awareness. Journal of Adolescent Health . 2023;73(1):S43–S54. doi: 10.1016/j.jadohealth.2022.09.034. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available from the Agency for healthcare Research and Quality's (AHRQ) Healthcare Cost and Utilization Project (HCUP). Restrictions apply to the availability of these data, which were used under license for this study.


Articles from Pediatric Diabetes are provided here courtesy of Maximum Academic Press

RESOURCES